1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32:S112–S119. PMID:
9820470.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Kimoto E, Shoji T, Shinohara K, Inaba M, Okuno Y, Miki T, et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes. 2003; 52:448–452. PMID:
12540620.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15:1014–1021. PMID:
10862640.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99:2434–2439. PMID:
10318666.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Kitahara T, Ono K, Tsuchida A, Kawai H, Shinohara M, Ishii Y, et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis. 2005; 46:688–696. PMID:
16183424.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002; 25:359–364. PMID:
12135313.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Kim YK, Lee MY, Rhee MY. A simple oscillometric measurement of pulse wave velocity: Comparison with conventional tonometric measurement. Korean J Med. 2004; 67:597–606.
8. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001; 103:987–992. PMID:
11181474.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57:450–458. PMID:
2936235.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Munakata M, Sakuraba J, Tayama J, Furuta T, Yusa A, Nunokawa T, et al. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res. 2005; 28:9–14. PMID:
15969249.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003; 26:615–622. PMID:
14567500.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. Atherosclerosis. 2003; 166:303–309. PMID:
12535743.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Lhee HY, Kim H, Lee KB, Lee Y. Serum Osteoprotegerin Levels and the Extent of Aortic Calcification in Hemodialysis Patients. Korean J Nephrol. 2006; 25:251–259.
14. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J. 2006; 82:357–362. PMID:
16754702.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001; 12:2117–2124. PMID:
11562410.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Tedesco MA, Natale F, Di Salvo G, Caputo S, Capasso M, Calabro R. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. J Hum Hypertens. 2004; 18:469–473. PMID:
14985776.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Suzuki E, Kashiwagi A, Nishio Y, Egawa K, Shimizu S, Maegawa H, et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care. 2001; 24:2107–2114. PMID:
11723092.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Uchida H, Nakamura Y, Kaihara M, Sugimoto T, Norii H, Sasaki M, et al. Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension. Hypertens Res. 2004; 27:545–550. PMID:
15492473.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001; 38:1408–1413. PMID:
11728983.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Hausberg M, Kosch M, Stam F, Heidenreich S, Kisters K, Rahn KH, et al. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation. Kidney Int. 2001; 59:1473–1479. PMID:
11260410.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant. 2002; 17:1513–1517. PMID:
12147804.
![crossref](/image/icon/bnr_ref_cross.gif)